SPHERA FUNDS MANAGEMENT LTD. - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 67 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$5,856,253
-8.3%
1,002,783
+5.2%
1.26%
+41.9%
Q3 2022$6,384,000
+123.2%
952,783
+40.2%
0.89%
+189.5%
Q2 2022$2,860,000
-41.1%
679,400
+76.9%
0.31%
-29.0%
Q4 2020$4,854,000
+59.5%
384,039
+23.9%
0.43%
+44.1%
Q3 2020$3,044,000
-56.3%
310,000
-55.8%
0.30%
-54.4%
Q2 2020$6,972,000
-22.1%
700,710
-30.8%
0.66%
-41.4%
Q1 2020$8,955,000
+593.1%
1,013,039
+623.6%
1.12%
+956.6%
Q4 2019$1,292,000
+57.0%
140,0000.0%0.11%
-16.5%
Q3 2019$823,000
-75.9%
140,000
-22.2%
0.13%
-74.6%
Q4 2015$3,415,000
-9.0%
180,000
-10.0%
0.50%
+4.4%
Q3 2015$3,754,000
+1490.7%
200,000
+1161.2%
0.48%
+1982.6%
Q2 2015$236,000
-95.8%
15,858
-95.8%
0.02%
-96.1%
Q1 2015$5,679,000
+184.2%
375,000
+150.0%
0.59%
+73.8%
Q4 2014$1,998,000
+598.6%
150,000
+560.8%
0.34%
+871.4%
Q3 2014$286,00022,7000.04%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
L1 Capital Pty Ltd 1,050,124$10,312,0003.31%
Alambic Investment Management, L.P. 19,934$196,0002.15%
INGALLS & SNYDER LLC 1,363,603$13,391,0000.92%
ACUTA CAPITAL PARTNERS, LLC 300,000$2,946,0000.80%
RA Capital Management 1,858,474$18,250,0000.33%
Perceptive Advisors 2,150,641$21,119,0000.31%
SPHERA FUNDS MANAGEMENT LTD. 310,000$3,044,0000.30%
Eversept Partners, LP 103,829$1,019,6010.23%
Opaleye Management Inc. 100,000$982,0000.19%
GSA CAPITAL PARTNERS LLP 58,095$570,0000.10%
View complete list of CONCERT PHARMACEUTICALS INC shareholders